| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00401-013-1093-X |
| P698 | PubMed publication ID | 23404370 |
| P50 | author | Otmar Wiestler | Q97949 |
| Roland Eils | Q30004000 | ||
| Stefan M. Pfister | Q39183179 | ||
| Andreas von Deimling | Q40381084 | ||
| Christel Herold-Mende | Q40381807 | ||
| Ralf Ketter | Q42289550 | ||
| Felix Sahm | Q42774262 | ||
| Rosario M. Piro | Q51075539 | ||
| Stefan Pusch | Q51075545 | ||
| Christian Koelsche | Q57614644 | ||
| Simon Matthias May | Q58210269 | ||
| David T. W. Jones | Q58388511 | ||
| P. Andrew Futreal | Q63232438 | ||
| David Capper | Q63366395 | ||
| Nathalia Giese | Q87716518 | ||
| Christian Mawrin | Q87844654 | ||
| Marcel Kool | Q90637389 | ||
| David E Reuss | Q98294091 | ||
| Leonille Schweizer | Q99412181 | ||
| Christian Hagenlocher | Q114726957 | ||
| P2093 | author name string | Patrick S Tarpey | |
| Philip J Stephens | |||
| Thomas Santarius | |||
| V Peter Collins | |||
| Christian Hartmann | |||
| Rainer König | |||
| Ruth Wellenreuther | |||
| Natalie Jäger | |||
| Jürgen Kraus | |||
| Doris Lenartz | |||
| Albert Becker | |||
| Jochen Meyer | |||
| Jana Mucha | |||
| Phillipp Kickingereder | |||
| P2860 | cites work | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway | Q21735927 |
| Mammalian Krüppel-Like Factors in Health and Diseases | Q24612560 | ||
| Dissecting the genomic complexity underlying medulloblastoma | Q24621907 | ||
| Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
| The structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiation | Q27666639 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
| Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation | Q28582825 | ||
| ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
| Secretory meningiomas: a benign subgroup causing life-threatening complications | Q33574558 | ||
| Sequence-specific error profile of Illumina sequencers | Q34185285 | ||
| KLF4, p21 and context-dependent opposing forces in cancer | Q34478868 | ||
| Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways | Q35641254 | ||
| Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study | Q36919876 | ||
| The seventh ring: exploring TRAF7 functions. | Q37959350 | ||
| Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray | Q38347517 | ||
| KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha | Q39841606 | ||
| Improving SNP discovery by base alignment quality | Q41909573 | ||
| Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations | Q42548316 | ||
| TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation | Q42773665 | ||
| PCR- and restriction endonuclease-based detection of IDH1 mutations | Q43278566 | ||
| NF2 mutations in secretory and other rare variants of meningiomas | Q48585454 | ||
| Web-based primer design for single nucleotide polymorphism analysis | Q49010083 | ||
| Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. | Q51804977 | ||
| Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats. | Q52972353 | ||
| Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases. | Q55067015 | ||
| Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas | Q58862180 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 351-358 | |
| P577 | publication date | 2013-02-12 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations | |
| P478 | volume | 125 |
| Q42445998 | AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry |
| Q36942228 | ARID1A and TERT promoter mutations in dedifferentiated meningioma |
| Q45997283 | Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. |
| Q47208014 | Advances in meningioma genetics: novel therapeutic opportunities |
| Q57163869 | An overview of meningiomas |
| Q43084857 | Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. |
| Q39290955 | BAP1 mutations in high-grade meningioma: implications for patient care |
| Q40682213 | Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis |
| Q58491122 | Brain Tumours |
| Q92446819 | Case-Based Review: meningioma |
| Q38810583 | Classification of human meningiomas: lights, shadows, and future perspectives |
| Q47578132 | Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients. |
| Q53117505 | Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. |
| Q48355463 | Clinicopathological and molecular characteristics of pediatric meningiomas |
| Q98158606 | Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas |
| Q64927814 | Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas. |
| Q36807618 | Copy number variation analysis identifies novel CAKUT candidate genes in children with a solitary functioning kidney. |
| Q89795838 | DNA methylation analysis for the treatment of meningiomas |
| Q38743450 | DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis |
| Q38680767 | Diagnostic Challenges in Meningioma |
| Q48109121 | Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas |
| Q38823997 | EANO guidelines for the diagnosis and treatment of meningiomas |
| Q58798211 | Emerging Medical Treatments for Meningioma in the Molecular Era |
| Q55456657 | Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry. |
| Q36483721 | Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. |
| Q50664835 | Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. |
| Q57191736 | Genetic Alterations of TRAF Proteins in Human Cancers |
| Q38953562 | Genetic landscape of meningioma |
| Q35072568 | Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma |
| Q35793582 | Genetic/molecular alterations of meningiomas and the signaling pathways targeted |
| Q48030508 | Genomic analysis reveals frequent TRAF7 mutations in intraneural perineuriomas. |
| Q46129842 | Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas |
| Q48857394 | High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression |
| Q93133413 | Identification of KIF11 As a Novel Target in Meningioma |
| Q90468370 | Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma |
| Q35741539 | Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma |
| Q93018924 | Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT |
| Q52764536 | KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas. |
| Q36472473 | KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer |
| Q38572601 | Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental models |
| Q51075492 | Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. |
| Q26741529 | Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications |
| Q90021888 | Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients |
| Q97519828 | Meningiomas: An Overview of the Landscape of Copy Number Alterations in Samples from an Admixed Population |
| Q91879154 | Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade |
| Q33729693 | Molecular Testing of Brain Tumor |
| Q38633637 | Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years |
| Q92817234 | Molecular characteristics of meningiomas |
| Q92353488 | Molecular characterization of localized pleural mesothelioma |
| Q38125031 | Molecular neuro-oncology in clinical practice: a new horizon |
| Q92264924 | Molecular pathology of tumors of the central nervous system |
| Q99616661 | Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma |
| Q88917856 | Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design |
| Q92810911 | Mutation Status and Epithelial Differentiation Stratify Recurrence Risk in Chordoid Meningioma-A Multicenter Study with High Prognostic Relevance |
| Q36785144 | Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma |
| Q37645016 | Overexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway |
| Q34682187 | PET Imaging in Patients with Meningioma - Report of the RANO/PET Group. |
| Q35943650 | Pathology and molecular genetics of meningioma: recent advances |
| Q100457833 | Peritumoral Brain Edema and Surgical Outcome in Secretory Meningiomas: a matched cohort analysis |
| Q94592174 | Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7 |
| Q92862814 | Recent Advances in Meningioma Immunogenetics |
| Q37420954 | Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas |
| Q53971614 | SMO mutant olfactory groove meningiomas-the next in line for targeted therapy. |
| Q96772861 | Scalp invasion by atypical or anaplastic meningioma is a risk factor for development of systemic metastasis |
| Q39725060 | Secretory Meningiomas: Increased Prevalence of Seizures Secondary to Edema Formation in a Rare Histologic Subtype. |
| Q88778968 | Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation |
| Q99357798 | Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02 |
| Q36849156 | TERT Promoter Mutations and Risk of Recurrence in Meningioma |
| Q38997320 | The Emerging Role of TRAF7 in Tumor Development |
| Q38565718 | The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor |
| Q39091307 | The new WHO 2016 classification of brain tumors-what neurosurgeons need to know |
| Q103826154 | The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges |
| Q91107708 | Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms |
| Q27853347 | Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade |
| Q50217988 | Tumors of the inner ear and adjacent structures |
| Q64928290 | Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. |
Search more.